Please login to the form below

Not currently logged in

compulsory licence

This page shows the latest compulsory licence news and features for those working in and with pharma, biotech and healthcare.

Bayer fails to overturn Nexavar compulsory licence in India

Bayer fails to overturn Nexavar compulsory licence in India

Natco Pharma allowed to sell cut-price version of cancer drug. Bayer's first attempt at overturning a compulsory license in India for its cancer drug Nexavar was knocked back yesterday ... Natco received the the compulsory licence in March 2012 on the

Latest news

  • India's patents versus India's patients India's patents versus India's patients

    Alternatively, we might see more examples of compulsory licensing in India where a government allows a third party to produce a patented product without the consent of the patent owner. . ... In a landmark decision earlier this year, India granted its

  • India could hit Roche and BMS with compulsory licences India could hit Roche and BMS with compulsory licences

    According to local newspaper reports, the Department of Pharmaceuticals is considering introducing 'compulsory licences' for Roche's breast cancer treatment Herceptin (trastuzumab), as well as Bristol-Myers Squibb's leukaemia medicine ... The first

  • Navigating the minefield

    The use of a compulsory licence is only allowed if efforts to obtain a voluntary licence on reasonable terms and conditions are made first. ... This has already happened in recent years. For instance, in November 2007, Thailand issued a compulsory

  • Emerging market: Brazil

    Once a nation with scant regard for patent rights (in 2007 the government issued a compulsory licence under World Trade Organization rules effectively to void the patent on Merck's HIV

  • Ecuador overrides 2,000 pharma patents

    These are quite specific and only envisage grant of such a licence under very limited circumstances. ... Medicine prices in Europe, for example, are usually determined through local mechanisms involving Governmental agencies and as such it is difficult

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Intellectual property threats in the BRIC markets Intellectual property threats in the BRIC markets

    Brazil, for example, used the threat of compulsory licensing to obtain discounts for various HIV drugs, before actually issuing a compulsory licence in 2007 for Stocrin. ... of the compulsory licence process for Herceptin, Sprycel and Ixempra,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....